Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2025-12-25 @ 2:34 AM
NCT ID:
NCT00712634
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Healthy participant
* Cytomegalovirus seropositive or seronegative
* HLA-A\*0201-positive
PATIENT CHARACTERISTICS:
* CBC within 1.5 times normal
* SMA-18 within 1.5 times normal
* Hepatitis B virus antigen seronegative
* Hepatitis C virus seronegative
* No diagnosis that is associated with immunodeficiency, including HIV infection
* No serious abnormalities by EKG (in participants ≥ 50 years of age)
* Not pregnant
PRIOR CONCURRENT THERAPY:
* More than 6 months since prior surgery
* No concurrent daily medications for chronic or current illness, except for the following:
* Thyroid replacement therapy
* Estrogen replacement therapy
* Dietary vitamins and protein supplements
* Antihistamine medication
* Anticholesterol medication
* Cardiac and antihypertensive medication
* Any medication, as determined by the principal investigator, that is not known or likely to be immunosuppressive
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00712634
Study Brief:
Protocol Section:
NCT00712634